Is new medication for myasthenia gravis available in the U.S.?
JAN 26, 2021
I am familiar with the use of a similar anesthetic (Bupivicaine) placed into an eye muscle to treat strabismus (misaligned eyes) pioneered by Dr. Alan Scott for patients with misaligned eyes not due to MG.
Bupivicaine was not effective for strabismus in CPEO (a condition that weakens eye muscle movements), and has not been studied in the U.S. for MG. Bupivicaine does improve some cases of acquired mild ptosis and may be worth trying experimentally for mild ptosis in patients who have otherwise recovered from MG. This therapy has not been vetted in the U.S. and is not FDA-approved.